terium, has recently been identified in several marine mammal species on the Pacific Coast of North America, but little is known about the epidemiology, transmission, and pathogenesis in these species. We tested sera archived from northern fur seals (NFS, Callorhinus ursinus; n5236) and Steller sea lions (SSL, Eumetopias jubatus; n572) sampled in Alaska for C. burnetii antibodies, and vaginal swabs from NFS (n540) for C. burnetii by qPCR. The antibody prevalence in NFS samples from 2009 and 2011 (69%) was significantly higher than in 1994 (49%). The antibody prevalence of SSL samples from 2007 to 2011 was 59%. All NFS vaginal swabs were negative for C. burnetii, despite an 80% antibody prevalence in the matched sera. The significant increase in antibody prevalence in NFS from 1994 to 2011 suggests that the pathogen may be increasingly common or that there is marked temporal variation within the vulnerable NFS population. The high antibody prevalence in SSL suggests that this pathogen may also be significant in the endangered SSL population. These results confirm that C. burnetii is more prevalent within these populations than previously known. More research is needed to determine how this bacterium may affect individual, population, and reproductive health of marine mammals.
Key words: Antibody prevalence, Coxiella burnetii, marine mammals, northern fur seal, Steller sea lion.
Coxiella burnetii, causative agent of human ''Q fever,'' is an obligate intracellular Gram-negative bacterium that is shed in reproductive tissues of infected females during parturition and transmitted via aerosolization and inhalation (Maurin and Raoult, 1999) . Although infection is often subclinical in many species, it can present clinically as infertility and abortion in ruminants (McQuiston et al., 2002) . The bulk of knowledge of coxiellosis pertains to terrestrial species, but case reports and studies of C. burnetii infection in marine mammals increasingly suggest that the pathogen may be common and clinically significant in marine mammals. Coxiella burnetii placentitis was documented in an ailing, and later euthanized, pregnant Pacific harbor seal (Phoca vitulina richardsi) found on a beach in Northern California in 1998 (Lapointe et al., 1999) . Coxiella burnetii was also found in the placenta of a dead pregnant Steller sea lion (SSL, Eumetopias jubatus) on the coast of Washington in 2008 (Kersh et al., 2010) . A 2010 cross-sectional survey of Pacific harbor seals, harbor porpoises (Phocoena phocoena), and SSL collected in the Pacific Northwest suggested that C. burnetii infection is common among multiple species of marine mammals in this region (Kersh et al., 2012) .
The significance of this reproductive pathogen in more northern regions is unclear. The northern fur seal (NFS; Callorhinus ursinus) is listed as vulnerable by the International Union for Conservation of Nature (IUCN) and, in 2010, 75% of 146 sampled placentas from Saint Paul Island, Alaska, were positive for C. burnetii by quantitative polymerase chain reaction (qPCR) (Duncan et al., 2012a) . The western stock of SSL, occupying much of the same range as the NFS, is listed as endangered (IUCN), but nothing is known about the prevalence of C. burnetii infection within this population. To better characterize the epidemiology of C. burnetii in a subset of Alaskan pinnipeds, we conducted a serosurvey using archived samples from NFS and SSL sampled at varying time points between 1994 and 2011. To examine shedding in these species, we tested a subset of vaginal swabs from these animals for the IS1111 and com1 genomic regions of C. burnetii by qPCR.
Serum samples were collected by venipuncture from live NFS and SSL during routine animal capture activities focused on animal behavior and physiology. Subadult male NFS were sampled immediately after being killed for subsistence harvest by native Alaskans. Vaginal swabs (sterile polyester, Puritan Medical, Guilford, Maine, USA) were collected from adult female NFS only during the same operations. All samples were frozen at 280 C until thawed for analysis. Indirect immunofluorescence assay was conducted on serum samples at the Centers for Disease Control and Prevention Q Fever Laboratory (Atlanta, Georgia, USA), as previously reported (Kersh et al., 2012) . Serial dilutions of sera from 1:128 to 1:16,384 were plated on slides coated with acetone-fixed C. burnetii strains Nine Mile Phase 1 and Phase 2. Binding was visualized using a fluorescein isothiocyanate-conjugated goat, anti-dog secondary antibody (Kirkegaard and Perry Laboratories, Gaithersburg, Maryland, USA). To eliminate reporting of false positives from cross-reactivity of antibodies, a positive cutoff was set at 1:128 similar to previous marine mammal studies (Kersh et al., 2012) .
Genomic DNA was extracted from adult NFS vaginal swabs from 2009 and 2011 using the QIAamp DNA Blood Mini Kit (Qiagen, Valencia, California, USA) according to the manufacturer's directions. Quantitative PCR was used to test the extracted DNA for C. burnetii com1 and IS1111 gene targets as described by Kersh et al. (2010) . Quantitative PCR was conducted utilizing the Applied Biosystems TaqManH Universal PCR Master Mix Kit, No AmpEraseH UNG (Applied Biosystems, Foster City, California, USA) and an Applied Biosystems 7500 96-well plate thermocycler. Descriptive and comparative statistics were conducted using commercially available software (SPSS 20, IBM, Inc., Chicago, Illinois, USA). The frequency of positive titers was compared between years, sexes, and age classes using the chisquare test.
Serology was conducted on 236 NFS samples collected from Saint Paul Island, Alaska (Fig. 1) . Samples included were from 72 subadult males from 1994, 30 adult females from 2009, 80 subadult males from 2011, 24 adult females from 2011, and 30 3-mo-old female pups from 2011. The antibody prevalences in NFS per year and stratified by sex and age are presented in Table 1 . Overall, 63% of samples had a titer $1:128. The frequency of positive titers varied significantly between years (P,0.001), with an apparent FIGURE 1. Sites where northern fur seal (Callorhinus ursinus) and Steller sea lion (Eumetopias jubatus) serum and vaginal swab samples were collected in Alaska, 1994 Alaska, -2011 increase from 49% in 1994 to 69% in 2009 and 2011. Similar percentages of antibodypositive animals were females (65%) and males (61%; P50.514). Only 2009 and 2011 samples were included in the ageclass analysis to eliminate the effect of an apparent temporal increase; 69% of these samples had a positive titer, and the frequency of antibody-positive animals varied significantly between age groups (P50.046), with positive titers in 50% of pups, 73% of subadults, and 74% of adults.
The frequency and range of titers to phase 1 and phase 2 antibodies are presented in Figure 2 . There was a wide range of titers, from 1:128 to 1:16,384, for both phase 1 and phase 2, with 64 animals having a titer of 1:256 for phase 1 and 51 animals having a titer of 1:512 for phase 2. Positive ($1:128) phase 2 titers were more common (n5145) than positive phase 1 titers (n5129), but the majority of positive NFS (85%) had both phase 1 and phase 2 titers.
Serology was conducted on 72 SSL samples, including seven samples from 2007 (three female and four male), 18 from 2008 (nine female and nine male), 13 from 2010 (11 female and two male), and 34 from 2011 (19 female and 15 male). All samples were from pups under 2 mo old at sampling. Steller sea lion sera were collected from eight islands in the Gulf of Alaska and Aleutian archipelago (Fig. 1) , including Agattu (n510), Akun (n57), Bogoslof (n59), Akutan (n58), Marmot (n55), Amak (n510), Sugarloaf (n59), and Ugamak (n514). Overall, 59% of samples were positive (Table 2) , and there was an increasing trend in antibody prevalence over time; however, there was no statistical difference in the frequency of positive animals by year (P50.16). There , 1994-2011. was no difference in antibody prevalence between females (60%) and males (59%, P50.721). As with NFS, there was a wide range of titers (Fig. 3) , with positive phase 1 titers more common (n544) than positive phase 2 titers (n539). Most samples were positive for both phase 1 and phase 2 (86%).
We conducted qPCR on 40 vaginal swabs from adult female NFS collected in October 2009 (n529) and October 2011 (n511). Thirty-two (80%) were antibody positive. Seven were positive for only phase 2; 25 were positive for both phase 1 and phase 2; and 35% had titers greater than 1:1,000. All swabs were PCR negative for C. burnetii.
Our results suggest that C. burnetii is a common pathogen in western stock SSL and NFS in Alaska. Previously, C. burnetii in SSL was only identified by PCR in one of two SSL placental samples from the Pacific Northwest (Kersh et al., 2012) . Although our sample sizes from some years were small, there appeared to be an increase in antibody prevalence from 2007 to 2011. Placentitis was evident in C. burnetii-infected SSL in a previous case report from 2008 (Kersh et al., 2010 as well as the Pacific Northwest (Kersh et al., 2012) , suggesting that infection with this pathogen could have a significant impact on reproductive health and, therefore, population health.
Our results show that C. burnetii was present in NFS as early as 1994. When the high prevalence of infection was identified in 2010 (Duncan et al., 2012a) , it was unknown if the pathogen was new to the population or simply newly identified.
Results of the present study suggest that the pathogen has been present in the population since the early 1990s; however, the prevalence became significantly higher in the 2000s. The 20% increase in antibody prevalence from 1994 to 2009 and 2011 is suggestive of an increasing trend of exposure within the NFS population, but it is also possible that there is cyclical variation in population antibody prevalence that could influence the observed difference over time. The high antibody prevalence is consistent with the high placental prevalence identified in this NFS population by qPCR (Duncan et al., 2012a, b) .
In humans, phase 2 titers are present during acute infection and can remain elevated for years, whereas phase 1 titers 2007-2011. are typically only elevated during chronic infection (Peacock et al., 1983) . If this antibody-antigen relationship holds true for marine mammals, the frequency of titers to phase 1 and phase 2 C. burnetii antigens suggests that NFS and SSL may experience both acute and chronic infections. Given the aggregation of animals at the time of parturition, it is hypothesized that animals could be re-exposed annually during pupping season.
Vaginal C. burnetii was not detected using the archived NFS vaginal swab samples. Given that 80% of the animals tested were antibody positive and the high placental prevalence in this population (Duncan et al., 2012a, b) , this negative finding is interesting. In iatrogenically infected domestic goats, C. burnetii was excreted in vaginal discharge up to 14 days after abortion (Bouvery et al., 2003) . However, given that the NFS swabs were collected in October, 3-4 mo after parturition and when the majority of adult females are pregnant (Gentry, 1998) , it is likely the organism had been cleared from the vaginal vault. To better characterize shedding, sample collection would ideally take place closer to time of parturition.
This study provides increasing epidemiologic information regarding C. burnetii in Alaskan marine mammals. Reproductive health is a critical component of population stability in any animal cohort. Coxiella burnetii infection may significantly alter cellular apoptosis in NFS placentas (Myers et al., 2012) , but the impact of this cellular alteration is difficult to extrapolate to the population level. Since both of these species have shown recent population declines, we recommend that further investigation into the role of reproductive pathogens, including C. burnetii, be continued for both species. C.M. was supported by an appointment to the Merial Veterinary Scholars Program and funded by the US Department of Agriculture, National Institute of Food and Agriculture, Animal Health and Disease Program. A.V.K. was supported by an
